Literature DB >> 12036209

Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus.

I Manolova1, M Dancheva, K Halacheva.   

Abstract

The IgG subclasses displayed by antibodies to four neutrophil cytoplasmic antigens were studied in 20 patients with systemic lupus erythematosus (SLE) by solid-phase enzyme immunoassays and monoclonal antibodies to human IgG subclasses. The IgG subclass reactivity of antineutrophil cytoplasmic antibodies (ANCA) was measured in six sera containing antiproteinase3 (PR3) antibodies, in five sera containing antimyeloperoxidase (MPO) antibodies, in sera containing antibactericidal/permeability-increasing protein (BPI) antibodies, and in ten sera containing antilactoferrin (LF) antibodies. The IgG subclass distribution of anti-dsDNA antibodies in eight sera was examined as well. IgGI was the predominant subclass for MPO-ANCA and LF-ANCA, whereas IgG1/IgG3 contributed mainly to anti-PR3, anti-BPI antibodies, and anti-dsDNA antibodies. In addition, we found elevated levels of the total IgG1 and IgG3 isotypes in the sera of our patients. Our results demonstrated a predominance of IgG1/IgG3 ANCA in SLE, suggesting that the isotype distribution of ANCA is a feature of antibody production in this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036209     DOI: 10.1007/s00296-002-0174-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.

Authors:  David A Savitsky; Hideyuki Yanai; Tomohiko Tamura; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

2.  Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.

Authors:  Irena Manolova; Maria Dantcheva
Journal:  Rheumatol Int       Date:  2004-11-11       Impact factor: 2.631

3.  Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.

Authors:  Domenico Caccavo; Amelia Rigon; Antonio Picardi; Sara Galluzzo; Marta Vadacca; Giovanni Maria Ferri; Antonio Amoroso; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2004-12-09       Impact factor: 2.980

4.  Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells.

Authors:  Hans U Lutz
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

5.  An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Authors:  Ittai Fattal; Noam Shental; Dror Mevorach; Juan-Manuel Anaya; Avi Livneh; Pnina Langevitz; Gisele Zandman-Goddard; Rachel Pauzner; Miriam Lerner; Miri Blank; Maria-Eugenia Hincapie; Uzi Gafter; Yaakov Naparstek; Yehuda Shoenfeld; Eytan Domany; Irun R Cohen
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

6.  IgG subclass serum levels in systemic lupus erythematosus patients.

Authors:  Gui-gao Lin; Jin-ming Li
Journal:  Clin Rheumatol       Date:  2009-07-12       Impact factor: 2.980

7.  Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.

Authors:  Dolores B Njoku; Jenelle L Mellerson; Monica V Talor; Douglas R Kerr; Nauder R Faraday; Ingrid Outschoorn; Noel R Rose
Journal:  Clin Vaccine Immunol       Date:  2006-02

8.  Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus.

Authors:  Ju-Yang Jung; Jin-Young Nam; Keun-Sil Ryu; In-Ok Son; Joo-Ho Shin; Wook-Young Baek; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

9.  Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.

Authors:  Sofie Lundgren; Xingmin Feng; Cassandra Kerr; Kohei Hosokawa; Jani Huuhtanen; Fumihiro Ishida; Hiroyoshi Nishikawa; Shinji Nakao; Jaroslaw Maciejewski; Neal S Young; Tiina Kelkka; Mikko Tyster; Mikko Keränen; Bhavisha Patel; Toru Kawakami; Yuka Maeda; Otso Nieminen; Tiina Kasanen; Pasi Aronen; Bhagwan Yadav; Hanna Rajala; Hideyuki Nakazawa; Taina Jaatinen; Eva Hellström-Lindberg; Seishi Ogawa; Satu Mustjoki
Journal:  Leukemia       Date:  2022-08-05       Impact factor: 12.883

10.  Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis.

Authors:  Astrid Hjelholt; Thomas Carlsen; Bent Deleuran; Anne Grethe Jurik; Berit Schiøttz-Christensen; Gunna Christiansen; Svend Birkelund
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.